Watson Pharmaceuticals (WPI) announces plans to restructure operations at its Corona, California...
Tuesday, January 8, 4:45 PM ETWatson Pharmaceuticals (WPI) announces plans to restructure operations at its Corona, California facility. As such, manufacturing and related support functions at the site will be reduced and activities at the facility going forward will be focused only on the production of oral contraceptives. The company anticipates the restructuring to be complete by the end of 2014, and expects to incur related costs of approximately $13M to $16M.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles